Home › Funds › Affinity Asset Advisors, LLC › TYRA
Affinity Asset Advisors, LLC position in TYRA
TYRA BIOSCIENCES INC · Health Care
Affinity Asset Advisors, LLC reported holding 850,000 shares of TYRA (TYRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$18.6M, representing 0.87% of its reported portfolio and ranking #31 among its reported holdings. Affinity Asset Advisors, LLC has disclosed TYRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's TYRA position evolved
Affinity Asset Advisors, LLC first disclosed a stake in TYRA in Q1 2026 at 257,512 shares (US$9.9M). The position peaked in Q3 2026 at 850,000 shares, worth US$18.6M. Across 3 filings, Affinity Asset Advisors, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 850,000 shares valued at US$18.6M — an increase of 649,988 shares quarter over quarter.. Notable position changes include a 325% increase in Q3 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 257.51K | $9.86M | New |
| Q2 2026 | 200.01K | $6.39M | Reduce |
| Q3 2026 | 850.00K | $18.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC) is a Health Care company. 45 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Siren, L.L.C. 3.40M sh · $74.27M · Q3 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held TYRA?
Affinity Asset Advisors, LLC has disclosed TYRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Affinity Asset Advisors, LLC's current position in TYRA?
As of Q3 2026, Affinity Asset Advisors, LLC holds 850.00K shares of TYRA (TYRA BIOSCIENCES INC), valued at $18.59M, representing 0.87% of its reported portfolio and ranking #31.
Has Affinity Asset Advisors, LLC been buying or selling TYRA?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in TYRA. The position peaked in Q3 2026 at 850.00K shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.